MedTrace Logo

Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI

NCT03057574 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-08-30

No results posted yet for this study

Summary

This study aims to record Efficacy, Safety and tolerability of Gonapure® prescribed for female subjects with infertility Undergoing IVF/ICSI

Conditions

  • Female Infertility

Interventions

DRUG

Follitropin Alfa

Patients must be prescribed Follitropin Alfa (Gonapure®)

Sponsors & Collaborators

  • MinaPharm Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Ashraf Kortam, PhD · Ain Shams University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-09
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03057574 on ClinicalTrials.gov